CFTR and cystic fibrosis: The introduction of cyclic adenosine monophosphate (cAMP) agonists, ATP or CFTR inhibitors in the perfusion fluid sequence can aid in not only distinguishing between CF and non-CF, but also quantify the success of a functional CFTR treatment (Rowe et al., 2011).